These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17576786)

  • 1. Rheumatoid arthritis: correlation between rheumatoid factor levels and CA-125 tumour marker elevation.
    Tsavaris N; Mavragani CP; Pikazis D
    Ann Rheum Dis; 2007 Jul; 66(7):980. PubMed ID: 17576786
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
    Valle Y; Ledezma-Lozano IY; Torres-Carrillo N; Padilla-Gutiérrez JR; Navarro-Hernández RE; Vázquez-Del Mercado M; Palafox-Sánchez CA; Armendáriz-Borunda J; Muñoz-Valle JF
    Scand J Rheumatol; 2009; 38(5):332-5. PubMed ID: 19579138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes].
    Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV
    Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
    Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The end of rheumatoid factor as we know it?
    Liao KP; Weinblatt ME; Solomon DH
    Arthritis Rheum; 2011 May; 63(5):1170-2. PubMed ID: 21538308
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis.
    Bosello S; Youinou P; Daridon C; Tolusso B; Bendaoud B; Pietrapertosa D; Morelli A; Ferraccioli G
    J Rheumatol; 2008 Jul; 35(7):1256-64. PubMed ID: 18528969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 11. Amtiperinuclear factor and antikeratin antibody: diagnostic use in a clinical laboratory setting.
    Alnigenis MN; Warikoo S; Barland P
    J Rheumatol; 2000 Aug; 27(8):2056-7. PubMed ID: 10955361
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
    Ljung L; Uddhammar A; Rantapää-Dahlqvist S
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1964-6. PubMed ID: 19764372
    [No Abstract]   [Full Text] [Related]  

  • 13. The tumor marker CA-125 and heart failure.
    Miñana G; Palau P; Núñez J; Sanchis J
    Rev Esp Cardiol; 2010 Oct; 63(10):1213-4. PubMed ID: 20875366
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
    Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CCP antibodies: the new rheumatoid factor in the serology of rheumatoid arthritis.
    van Venrooij WJ; Vossenaar ER; Zendman AJ
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S17-9. PubMed ID: 15309772
    [No Abstract]   [Full Text] [Related]  

  • 16. Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?
    Symmons DP
    Rheumatology (Oxford); 2007 May; 46(5):725-6. PubMed ID: 17215261
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2007; 36(2):97-100. PubMed ID: 17476614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid factors antedating clinical rheumatoid arthritis.
    Aho K; Heliövaara M; Maatela J; Tuomi T; Palosuo T
    J Rheumatol; 1991 Sep; 18(9):1282-4. PubMed ID: 1757925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of granulocyte elastase-alpha-proteinase inhibitor complex in patients with rheumatoid arthritis: measurements with a system free from rheumatoid factor interference.
    Fujimori J; Yoshino S; Hirata I
    J Rheumatol; 1996 Mar; 23(3):571. PubMed ID: 8833009
    [No Abstract]   [Full Text] [Related]  

  • 20. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.
    Sihvonen S; Korpela M; Mustila A; Mustonen J
    J Rheumatol; 2005 Nov; 32(11):2089-94. PubMed ID: 16265684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.